Recent studies show that exposure to GLP1-RA in the first trimester is not associated with a risk of major birth defects when compared with diabetes or obesity
A simple record of dose changes, meal timing, and digestive symptoms may help you and your healthcare professional understand what adjustments could improve your experience
Contrave and Wegovy are two brand-name prescription drugs approved for weight management in adults with obesity or who are overweight with at least one weight-related condition, such as high blood pressure (hypertension) or Type 2 diabetes
A comprehensive analysis of 43,365 individuals from two US healthcare databases indicated that GLP-1 RAs do not elevate the risk of pulmonary aspiration during upper gastrointestinal endoscopy in patients with T2DM when compared to SGLT-2 inhibitors, yielding a pooled risk ratio of 0.98 (95% CI, 0.73 to 1.31) among GLP-1 RA users
[5] Each formulation has distinct dosing schedules, with some administered daily and others weekly
